Literature DB >> 11490253

Patient reported complications after prostate brachytherapy.

B H Han1, K C Demel, K Wallner, W Ellis, L Young, K Russell.   

Abstract

PURPOSE: Prostate brachytherapy has gained popularity due partly to the low rates of short-term complications shown in studies from highly select clinical practices. These series rely on medical records generated by the treating physician and are prone to underreport complications. We summarize the complication reports obtained directly from patients to establish a more realistic incidence of treatment related problems.
MATERIALS AND METHODS: In 1997, 160 consecutive patients treated with prostate brachytherapy at the University of Washington were studied. A questionnaire was designed to determine the rate of complications occurring within 1 year of the procedure. The questions were formulated for ease of use and conciseness, while accounting for easily recalled events associated with complications. A total of 147 (92%) patients completed the questionnaire.
RESULTS: There were 8 (5%) patients who required hospital admission for an average of 2 days (range 1 to 7) as a result of the procedure. A total of 56 (38%) patients required nonroutine visits with a physician in an office setting or at an emergency room. Radiation proctitis diagnosed by endoscopy developed in 8 (5%) patients but no one needed surgical intervention. A total of 47 (32%) patients required urinary catheterization at some point after implantation.
CONCLUSIONS: We demonstrated a higher rate of short-term complications than those previously reported. Fortunately, the majority of side effects were self-limited and no treatment related mortality or cardiovascular morbidity was seen. Our findings may provide a more realistic account of the complications likely to occur after implantation than might be surmised from previous reports.

Entities:  

Mesh:

Year:  2001        PMID: 11490253

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Acute urinary morbidity following I-125 prostate brachytherapy.

Authors:  Toshio Ohashi; Atsunori Yorozu; Kazuhito Toya; Shiro Saito; Tetsuo Momma
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

2.  Serial changes of international prostate symptom score following I-125 prostate brachytherapy.

Authors:  Toshio Ohashi; Atsunori Yorozu; Kazuhito Toya; Shiro Saito; Tetsuo Momma
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

3.  Managing and preventing acute urinary retention.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

4.  Interfractional fluctuation of rectal dose in high dose rate brachytherapy for prostate cancer.

Authors:  Hime Ishikawa; Morio Sato; Shintaro Shirai; Kazushi Kishi; Yoshitaka Naya; Hisaki Tokunaga
Journal:  Radiat Med       Date:  2006-11-24

5.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

Authors:  Omid C Farokhzad; Jianjun Cheng; Benjamin A Teply; Ines Sherifi; Sangyong Jon; Philip W Kantoff; Jerome P Richie; Robert Langer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

6.  Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy.

Authors:  Xuesong Li; Dong Fang; Matthew R Cooperberg; Jared M Whitson; Tom F Lue; Liqun Zhou; Katsuto Shinohara
Journal:  World J Urol       Date:  2013-10-19       Impact factor: 4.226

7.  [Complications and side effects of low dose rate brachytherapy for the treatment of prostate cancer: data on a 13 year follow-up study from Mannheim].

Authors:  L Trojan; K Harrer; J Schäfer; M Voss; G Welzel; C Bolenz; F Wenz; P Alken; M-S Michel
Journal:  Urologe A       Date:  2007-11       Impact factor: 0.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.